ESPR Esperion Therapeutics reports Q4 2025 EPS miss shares post small gains even as earnings lag analyst estimates What Eagle EICA doing to improve profitability Eagle posts 035 EPS 1 below estimates on mild headwinds US Dirty Soda Category Expansion and Industry Trend Analysis Invesco CurrencyShares Japanese Yen Trust FXY Navigating US Dollar Weakness and CrossAsset ETF Allocation Opportunities